GPT and tuberculosis: At the end of 2 months of TB treatment, ALT, AST, ALP and total bilirubin were significantly (P < 0.001) lower in test group participants (Median: 8.4, 22.1, 64.7 and 3.1) compared to participants in the control group (Median: 74.95, 56.25, 85.4 and 8.25) (Table 2).